MedTrace Logo

A Digital Antimicrobial Stewardship Smartphone Application to Combat AMR: the AB-assistant

NCT03793946 · Status: UNKNOWN · Phase: NA · Type: INTERVENTIONAL · Enrollment: 1080

Last updated 2020-08-04

No results posted yet for this study

Summary

Optimal prescribing of antimicrobials is becoming increasingly challenging because of the growing complexity of guidelines and constantly changing distribution of infectious pathogens. Prescribing antimicrobials appropriately according to local guidelines optimizes therapy for the individual patient and reduces the emergence of resistance. By adapting and evaluating a smartphone based app containing local guidelines we aim to study appropriate prescribing of antimicrobials by physicians in three hospitals (Netherlands, Sweden and Switzerland).

Conditions

  • Anti-Infective Agents
  • Mobile Applications
  • Quality Improvement
  • Antimicrobial Stewardship

Interventions

OTHER

AB-assistant

The AB-assistant is an antimicrobial stewardship smartphone application that offers local antimicrobial guidelines to physicians currently assessed per website or paper/digital booklet.

Sponsors & Collaborators

  • Erasmus Medical Center

    collaborator OTHER

  • University Hospital, Geneva

    collaborator OTHER

  • Uppsala University Hospital

    collaborator OTHER

  • University of Calgary Cumming School of Medicine

    collaborator UNKNOWN

  • Annelies Verbon

    lead OTHER

Principal Investigators

  • B D Huttner, MD, MS · University Hospital, Geneva

  • T Tängdén, MD, PhD · Uppsala University

  • John Conly, Prof. Dr. · University of Calgary Cumming School of Medicine

Study Design

Allocation
RANDOMIZED
Purpose
TREATMENT
Masking
SINGLE
Model
PARALLEL

Eligibility

Min Age
18 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2020-09-30
Primary Completion
2021-09-30
Completion
2022-01-31

Countries

  • Canada
  • Netherlands
  • Sweden
  • Switzerland

Study Locations

More Related Trials

Entities

Companies

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT03793946 on ClinicalTrials.gov